Beta Bionics, Inc. (BBNX) Cash from Operations (2024 - 2026)

Beta Bionics (BBNX) posted Cash from Operations of 23832000.0 for Q1 2026, down 176.25% sequentially from 8627000.0 in Q4 2025, and down 19.31% YoY from 29534942.3 in Q1 2025.

Beta Bionics, Inc. (BBNX) Cash from Operations (2024 - 2026) Analysis & Trends

Beta Bionics (BBNX) has 3 years of Cash from Operations data on file, last reported at 23832000.0 in Q1 2026.

  • Quarterly Cash from Operations fell 19.31% year-over-year to 23832000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 54782000.0 (up 2.36% YoY) and the FY2025 annual result came in at 50925000.0, down 5.49% from the prior year.
  • Cash from Operations declined to 23832000.0 in Q1 2026 per BBNX's latest filing, from 8627000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 8627000.0 in Q4 2025, with the low at 23832000.0 in Q1 2026.
  • Average Cash from Operations over 3 years is 13670000.0, with a median of 12237000.0 recorded in 2024.
  • The widest YoY moves for Cash from Operations: up 39.58% in 2025, down 64.48% in 2025.
  • Beta Bionics' Cash from Operations stood at 14279000.0 in 2024, then jumped by 39.58% to 8627000.0 in 2025, then sank by 176.25% to 23832000.0 in 2026.
  • Business Quant data shows BBNX's Cash from Operations at 23832000.0 in Q1 2026, 8627000.0 in Q4 2025, and 8729000.0 in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 -23.83 Mn
Mar 31, 2026 -23.83 Mn
Dec 31, 2025 -8.63 Mn
Dec 31, 2025 -8.63 Mn
Sep 30, 2025 -8.73 Mn
Sep 30, 2025 -8.73 Mn
Jun 30, 2025 -13.59 Mn
Jun 30, 2025 -13.59 Mn
Mar 31, 2025 -19.98 Mn
Mar 31, 2025 -19.98 Mn
Dec 31, 2024 -14.28 Mn
Dec 31, 2024 -14.28 Mn
Sep 30, 2024 -9.61 Mn
Sep 30, 2024 -9.61 Mn
Jun 30, 2024 -12.24 Mn
Jun 30, 2024 -12.24 Mn
Mar 31, 2024 -12.14 Mn
Mar 31, 2024 -12.14 Mn